
Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex
Keywords: glutamate; KAT II; Kynurenic acid; Microelectrode array; Prefrontal cortex; Schizophrenia; ACh; acetylcholine; α7nAChR; alpha7 nicotinic acetylcholine receptor; Gluox; glutamate-sensitive; HPBCD; hydroxyl-propyl-beta-cyclodextrin; KYNA; kynurenic acid; K